Connect with us

Hi, what are you looking for?

BioTechnology

Baleon Capital Closes First Fund to Provide Capital Infusion to Healthcare Startups

Baleon Capital, a one-year-old venture capital firm started by investment veteran Jon Kaiden, closed its first fund to invest in pre-Series A and Series A companies focused on health and medical care in the United States.

investment

Baleon Capital Closes First Fund to Provide Capital Infusion to Healthcare Startups

Baleon Capital, a one-year-old venture capital firm started by investment veteran Jon Kaiden, closed its first fund to invest in pre-Series A and Series A companies focused on health and medical care in the United States.

Before starting the Miami-based firm, Kaiden was a founding member and principal of Sopris Capital, where he told TechCrunch his track record of internal return on revenue landed him in the top 95th percentile of all early-stage funds. Baleon is a mash-up of the names of Kaiden’s four children: Brooke, Allie, Leo and Nicole.

Though he did not disclose the fund amount, Kaiden did say he was targeting $100 million for the fund. He expects to initially be able to invest in between eight and 12 companies with $5 million to $10 million in check sizes. If he is able to get the $100 million, Kaiden plans for nearly three-fourths to go into initial investments and the rest for follow-on or new opportunities that come in.

Despite the pandemic, the past year was a “great environment to raise a fund,” he said. After running Sopris for 18 years, he thought it was time to raise a fund especially targeting the healthcare industry, which saw a boom.

“The pandemic tweaked a lot of the industry, especially virtual healthcare, and sped up a lot of things to be more efficient,” Kaiden said. “However, doctors are still among the slowest group to adopt technology.”

As a result, Baleon Capital will invest in companies building the new digital infrastructure for healthcare, aimed at reducing costs, improving access and solving inefficiencies that are hindering patient care. In addition to healthcare, the firm has identified opportunities in vertical SaaS, like finance and real estate.

Baleon’s first fund invested in three companies: Mantra Health, a digital mental health clinic on a mission to improve access to evidence-based mental healthcare for young adults; LifeLink, which is building infrastructure for modern patient engagement; and ClearStep, a care navigation platform leveraging artificial intelligence to match patients to the right provider based on their symptoms, insurance and location.

As healthcare settles into its new digital transformation, Kaiden sees an industry that will rely more heavily on data interoperability as electronic medical records and gleaning insights from big data will evolve. He expects that to help reduce costs without reducing patient satisfaction and provide better health outcomes.

“It’s always a good time in healthcare, and there will always be companies that are disruptive,” Kaiden said. “Healthcare is 18% of the country’s GDP — that is a huge part of our economy, and it is inefficient. That makes it ripe for entrepreneurs to disrupt it.”

Seen on TechCrunch: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Exclusives

IoT is transforming healthcare through wearables, SaMD, and AI. MedTech needs strong branding for the efficiency and cost savings this will provide.

Digital Health

The lack of standardization is a huge problem in the diagnosis and tracking of neurological disorders: because they are so complex and often slow...

FDA

System creates 3D models of the heart with unprecedented anatomical details, allowing physicians to better plan and personalize therapeutic interventions

FDA

Linear Health Sciences has received U.S. FDA clearance and Health Canada approval of its Orchid SRV, a tension-activated breakaway safety release valve designed to reduce the...

You May Also Like

Exclusives

Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare industry by storm. Innovators across the HealthTech...

Exclusives

PRIA clients are provided a high-touch, white-glove service to support their patient access services.

Exclusives

In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...

Exclusives

The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.